Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP9X | Q93008 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 3/20 | 0.31 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28044985 | 0.86 | USP9X (0.35) | USP9XSLC6A9 | |
| SCHEMBL15524327 | 0.85 | KDM1A (0.39) | USP9XDPP4KDM1AAMY1APTPN1 | |
| SCHEMBL17380568 | 0.81 | HDAC1 (0.39) | DPP4MAPTHTT | |
| SCHEMBL20483601 | 0.79 | DPP4 (0.40) | USP9XDPP4SLC6A9 | |
| SCHEMBL2364142 | 0.77 | DPP4 (0.41) | USP9XDPP4SLC6A9 | |
| SCHEMBL9963137 | 0.75 | DPP4 (0.38) | DPP4 | |
| SCHEMBL28877856 | 0.74 | HDAC1 (0.42) | USP9XKDM1ALMNATSHRSLC6A9 | |
| SCHEMBL30706257 | 0.74 | POLB (0.44) | USP9XPOLBALDH1A1 | |
| SCHEMBL30706276 | 0.73 | USP9X (0.39) | USP9XMAPTALDH1A1 | |
| SCHEMBL23430681 | 0.73 | DPP4 (0.40) | USP9XDPP4KDM1AAMY1APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3159344-B1 | AMINO PYRANOID RING DERIVATIVE AND COMPOSITION AND USE THEREOF | SICHUAN HAISCO PHARMACEUTICAL CO LTD (CN) | 2023-09-20 | — | — | EP | disclosed |
| US-10065962-B2 | Amino pryan ring derivative and composition and use thereof | SICHUAN HAISCO PHARMACEUTICAL CO., LTD (CN) | 2018-09-04 | — | — | US | disclosed |
| EP-3159344-A1 | AMINO PYRANOID RING DERIVATIVE AND COMPOSITION AND USE THEREOF | Sichuan Haisco Pharmaceutical Co., Ltd. (CN) | 2017-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065962-B2 | Amino pryan ring derivative and composition and use thereof | DPP4, DPP8, DPP3 | USP9X 2304/4885DPP4 1/4885POLB 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.